Clinical trial
Dysregulated Tyrosine Kinase Signaling in Leukemia
NCT00277056 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dysregulated Tyrosine Kinase Signaling in Leukemia
- Lead sponsor
- University of New Mexico
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 31, 2002
- Completion date
- October 31, 2005
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.